METHODS OF INTRAVENOUSLY ADMINISTERING DOFETILIDE
Methods of administering dofetilide in an amount effective for treating a cardiovascular condition are described. An initial IV loading dose can be administered intravenously as a loading dose, such as in the range of ±50% of a target oral dose, and over a duration of from 1-5 hours. One or more maintenance dose(s) can be given orally (and/or infused intravenously as an IV maintenance dose over a duration of from 1-5 hours), such as in an amount of up to about 1000 μg. In embodiments, the loading and maintenance dose(s) are selected to enable maximum serum concentration of the subject in less than 24 hours, such as within 1 hour, from the start of the IV administering and within a range of ±25% of a C max at steady state predicted for the subject for an oral dosing protocol of 125 μg, 250 μg, or 500 μg dofetilide.
1 . A method of administering dofetilide, comprising:
administering an IV dosage of dofetilide to a subject over a period of time in the range of about 1-5 hours.
2 . The method of claim 1 , comprising:
administering the IV dosage in an amount of up to 1000 μg; and
after administering the IV dosage, administering one or more IV maintenance dose and/or one or more oral maintenance dose of dofetilide to the subject.
3 . The method of claim 2 , wherein one or more oral maintenance dose of dofetilide is administered to the subject and in an amount of 125 μg, 250 μg or 500 μg.
4 . The method of claim 2 , wherein:
the IV dosage is administered while the subject is in a facility capable of providing cardiac resuscitation and electrocardiographic monitoring; and
administration of one or more of the maintenance doses of dofetilide is performed before the subject is discharged from the facility capable of providing cardiac resuscitation and electrocardiographic monitoring.
5 . The method of claim 2 , wherein:
the IV dosage is administered while the subject is in a facility capable of providing cardiac resuscitation and electrocardiographic monitoring; and
administration of one or more of the maintenance doses of dofetilide is performed after the subject is discharged from the facility capable of providing cardiac resuscitation and electrocardiographic monitoring.
6 . The method of claim 1 , wherein the subject has a cardiovascular condition selected from atrial fibrillation, atrial flutter, atrial tachycardia, ventricular tachycardia, hemodynamically stable or unstable ventricular tachycardia, paroxysmal atrial fibrillation, ventricular fibrillation, ventricular arrhythmia, premature ventricular contractions (PVCs), paroxysmal supraventricular tachycardia, supraventricular tachycardia, junctional ectopic tachycardia, junctional tachycardia, heart failure, coronary artery disease, and pulmonary artery hypertension.
7 . The method of claim 2 , wherein:
the IV dosage is administered in an amount of:
(a) about 62.5-187.5 μg dofetilide and one of more of the oral maintenance doses of dofetilide is administered in an amount of 125 μg;
(b) about 125-375 μg dofetilide and one of more of the oral maintenance doses of dofetilide is administered in an amount of 250 μg; or
(c) about 250-1000 μg dofetilide and one of more of the oral maintenance doses of dofetilide is administered in an amount of 500 μg.
8 . The method of claim 2 , wherein:
the IV dosage is administered in an amount of up to 1000 μg dofetilide; and
the IV maintenance dose(s) are administered in an amount of up to about 1000 μg.
9 . The method of claim 8 , wherein:
the IV dosage is administered over a period of time of about 1 hour; and
the IV maintenance dose(s) are administered over a period of time of about 5 hours.
10 . The method of claim 9 , wherein:
the IV dosage is administered in an amount of 250-500 μg dofetilide;
a first IV maintenance dose of 250-500 μg dofetilide is administered 6-12 hours after initiation of the IV dosage of dofetilide.
11 . The method of claim 8 , wherein:
the IV dosage is administered over a period of time of about 5 hours; and
the IV maintenance dose(s) are administered over a period of time of about 5 hours.
12 . The method of claim 11 , wherein:
the IV dosage is administered in an amount of 250-500 μg dofetilide; and
a first IV maintenance dose of 250-500 μg dofetilide is administered 2-12 hours after initiation of the IV dosage of dofetilide.
13 . A method of administering dofetilide, comprising:
(A) before administering an IV dosage of dofetilide to a subject, determining a creatinine clearance (CrCl) of the subject, and selecting an amount of dofetilide to administer to the subject based on the creatinine clearance;
(B) administering to the subject the IV dosage comprising the selected amount of dofetilide based on the CrCl, wherein the IV dosage is administered over a period of about 1-5 hours and is administered to the subject in a facility capable of providing cardiac resuscitation and continuous electrocardiographic monitoring.
14 . The method of claim 13 , wherein the selected amount of dofetilide to administer to the subject is further based on a target oral dose of dofetilide.
15 . The method of claim 13 , wherein the IV dosage of dofetilide is administered:
in a first higher amount for the subject with a CrCl of 20 mL/min to <40 mL/min; and
in a second lower amount for the subject with a CrCl of 40 mL/min or greater.
16 . The method of claim 13 , further comprising administering one or more IV or oral maintenance dose of dofetilide after administering the IV dosage of dofetilide.
17 . The method of claim 14 , wherein:
the IV dosage comprising the selected amount of dofetilide based on the creatinine clearance and the target oral dose of the subject comprises an amount of dofetilide as follows:
Intravenous Dosage of Dofetilide
Maintenance
Subject's CrCl
Subject's CrCl
Subject's CrCl
Dose
>60 mL/min
40-60 mL/min
20 to <40 mL/min
125 μg
50-150 μg
100-250 μg
up to 125 μg
250 μg
100-350 μg
200-500 μg
up to 250 μg
500 μg
300-800 μg
400-1000 μg
up to 500 μg.
18 . The method of claim 13 , further comprising:
selecting an amount of dofetilide to administer as one or more IV maintenance dose(s) to the subject based on the creatinine clearance;
administering one or more IV maintenance dose over a period of about 1-5 hours;
wherein the IV maintenance dose is administered to the subject in or out of a facility capable of providing cardiac resuscitation and continuous electrocardiographic monitoring; and
wherein the IV dosage and the IV maintenance dose each independently comprise a selected amount of dofetilide based on the creatinine clearance as follows:
IV and/or IV Maintenance Dose(s) of Dofetilide
Subject's CrCl
Subject's CrCl
Subject's CrCl
>60 mL/min
40-60 mL/min
20 to <40 mL/min
50-150 μg
100-250 μg
up to 125 μg
100-350 μg
200-500 μg
up to 250 μg
300-1000 μg
400-1000 μg
up to 500 μg.
19 . The method of claim 1 , wherein the subject is discharged with instructions to self-administer an oral dose and/or one or more subsequent oral doses of dofetilide every 12 to 48 hours.
20 . The method of claim 1 , further comprising:
obtaining a QT or QTc interval of the subject before administration of the IV dosage; and
obtaining a QT or QTc interval of the subject during or after administration of the IV dosage, but before administration of any oral dosage;
wherein when the QT or QTc interval during or after administering the IV dosage is less than a 15% increase from the QT or QTc interval before administering the IV dosage, then administering one or more IV or oral maintenance dose of dofetilide.
21 . The method of claim 18 , further comprising:
if one or more IV or oral maintenance doses are administered, then obtaining a QT or QTc interval of the subject after a first IV or oral maintenance dose;
wherein (a) when the QT or QTc interval obtained after administering the first IV or oral maintenance dose is less than a 15% increase from the QT or QTc interval before administering the IV dosage, then administering a second IV or oral maintenance dose comprising an amount of dofetilide that is the same amount as the first IV or oral maintenance dose or (b) when the QT or QTc interval obtained after administering the first IV or oral maintenance dose is equal to or more than a 15% increase from the QT or QTc interval before administering the IV dosage, then administering a second IV or oral maintenance dose comprising an amount of dofetilide that is less than the amount of dofetilide of the first IV or oral maintenance dose.
22 . The method of claim 1 , wherein the subject achieves or is capable of achieving a maximum serum concentration that approximates a predicted C max at steady state for the IV dosage.